FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

SCA Pharmaceuticals Potassium PHOSphate added to 0 Recall

Potassium PHOSphate added to 0

SCA Pharmaceuticals · Little Rock, AR

Risk level
Class II
Reported by FDA
Jul 19, 2017
Recall ID
D-0979-2017
Check your lot numberHow we source this data

Summary

SCA Pharmaceuticals recalled Potassium PHOSphate added to 0 starting Jun 21, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0979-2017 on Jul 19, 2017. Reason: Lack of sterility assurance. Status: Terminated.

Why it was recalled

Lack of sterility assurance

Product description

Potassium PHOSphate added to 0.9% Sodium Chloride 250 mL Bag 30 mMol (44 mEq K+) Total Approximate Volume 260 mL, Rx only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0843-40

Lot numbers, UPCs & expiration codes

Lot #: 20170511@58, Exp 6/25/2017

Where it was sold

LA, PA, NY, WI

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0979-2017
Classification
Class II
Status
Terminated
Recall initiated
Jun 21, 2017
FDA report date
Jul 19, 2017
Quantity
20 bags
Recall type
Voluntary: Firm initiated
Recalling firm
SCA Pharmaceuticals

Original FDA data

Every field from FDA enforcement report D-0979-2017, exactly as published.

Show all FDA fields
City
Little Rock
State
AR
Status
Terminated
Country
United States
Event ID
77600
Address
8821 Knoedl Ct
Code information
Lot #: 20170511@58, Exp 6/25/2017
Postal code
72205-4600
Report date
Jul 19, 2017
Product type
Drugs
Recall number
D-0979-2017
Classification
Class II
Recalling firm
SCA Pharmaceuticals
Product quantity
20 bags
Termination date
Apr 3, 2019
Reason for recall
Lack of sterility assurance
Voluntary / mandated
Voluntary: Firm initiated
Product description
Potassium PHOSphate added to 0.9% Sodium Chloride 250 mL Bag 30 mMol (44 mEq K+) Total Approximate Volume 260 mL, Rx only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0843-40
Distribution pattern
LA, PA, NY, WI
Recall initiation date
Jun 21, 2017
Initial firm notification
Letter
Center classification date
Jul 13, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0979-2017, published Jul 19, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls